PT Ricky Putra Globalindo Tbk (RICY.JK)
IDR 72.0
(0.0%)
IDR 72.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 868.48 Billion | 1214.49 Billion | 1375.93 Billion | 1286.05 Billion | 2151.32 Billion | 2107.86 Billion |
| Cost of Revenue | 681.34 Billion | 1002.43 Billion | 1177.77 Billion | 1085.72 Billion | 1827.62 Billion | 1757.39 Billion |
| Gross Profit | 187.13 Billion | 212.05 Billion | 198.15 Billion | 200.33 Billion | 323.69 Billion | 350.47 Billion |
| Operating Expenses | 170.17 Billion | 168.17 Billion | 153.12 Billion | 183.03 Billion | 222.68 Billion | 226.62 Billion |
| Selling, General and Administrative Expenses | 159.41 Billion | 84.01 Billion | 70.36 Billion | 86.97 Billion | 110.65 Billion | 106.71 Billion |
| Research and Development Expenses | 455.16 Million | 433.55 Million | 572.81 Million | 527.36 Million | 697.75 Million | 668.64 Million |
| Other Expenses | - | 83.73 Billion | 82.19 Billion | 95.52 Billion | 111.33 Billion | -215.26 Million |
| Cost and Expenses | 855.13 Billion | 1170.61 Billion | 1330.9 Billion | 1268.75 Billion | 2050.31 Billion | 1984.02 Billion |
| Operating Income | 13.34 Billion | 2.63 Billion | 33.85 Billion | 16.33 Billion | 101.5 Billion | 123.84 Billion |
| Interest Expense | 88.65 Billion | 68.03 Billion | 92.79 Billion | 81.85 Billion | 72.67 Billion | 61.3 Billion |
| Income Tax Expense | 888.1 Million | 3.14 Billion | 5.09 Billion | 2.91 Billion | 11.61 Billion | 11.36 Billion |
| Earnings before Tax | -59.78 Billion | -66.22 Billion | -61 Billion | -74.66 Billion | 28.83 Billion | 29.84 Billion |
| Net Income | -59.81 Billion | -69.37 Billion | -66.09 Billion | -77.57 Billion | 18.51 Billion | 11.73 Billion |
| Earnings Per Share Basic | -93.22 | -108.11 | -103.00 | -120.89 | 28.85 | 18.28 |
| Earnings Per Share Diluted | -93.22 | -108.11 | -103.00 | -120.89 | 28.85 | 18.28 |
| Weighted Average Shares Outstanding | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million |
| Gross Margin | 0.22 | 0.17 | 0.14 | 0.16 | 0.15 | 0.17 |
| EBIT Margin | 0.07 | 0.01 | 0.03 | 0.02 | 0.05 | 0.05 |
| Profit Margin | -0.07 | -0.06 | -0.05 | -0.06 | 0.01 | 0.01 |
| EBITDA | 59.98 Billion | 41.09 Billion | 85.49 Billion | 78.49 Billion | 177.91 Billion | 153.94 Billion |
| Earnings Before Tax Margin | 0.02 | 0.00 | 0.02 | 0.01 | 0.05 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 206 Billion | 239.2 Billion | 205.81 Billion | 860.15 Billion | 230.42 Billion | 169.87 Billion |
| Cost of Revenue | 176.76 Billion | 186.41 Billion | 171.9 Billion | 693.56 Billion | 187.11 Billion | 113.69 Billion |
| Gross Profit | 29.23 Billion | 52.79 Billion | 33.9 Billion | 166.58 Billion | 43.31 Billion | 56.18 Billion |
| Operating Expenses | 38.87 Billion | 43.04 Billion | 66.51 Billion | 170.45 Billion | 38.81 Billion | 34.54 Billion |
| Selling, General and Administrative Expenses | 36.97 Billion | 22.12 Billion | 60.16 Billion | - | 17.89 Billion | 14.64 Billion |
| Research and Development Expenses | 62.9 Million | 148.79 Million | 186.57 Million | - | 78.77 Million | 117.84 Million |
| Other Expenses | -1.84 Billion | 2.36 Billion | -6.16 Billion | -10.58 Billion | 2.4 Billion | 3.06 Billion |
| Cost and Expenses | 215.64 Billion | 229.45 Billion | 238.42 Billion | 864.02 Billion | 225.93 Billion | 148.23 Billion |
| Operating Income | -9.63 Billion | -962.36 Million | -32.61 Billion | -3.86 Billion | -8.6 Billion | 25.81 Billion |
| Interest Expense | 18.48 Billion | 17.99 Billion | 20.74 Billion | 84.63 Billion | 18.04 Billion | 28 Billion |
| Income Tax Expense | -224.69 Million | 573.92 Million | -670.45 Million | 888.1 Million | -390.83 Million | -1 Billion |
| Earnings before Tax | -46.4 Billion | -19.96 Billion | -41.56 Billion | -59.78 Billion | -26.5 Billion | -1.07 Billion |
| Net Income | -44.79 Billion | -18.85 Billion | -41.25 Billion | -59.81 Billion | -25.21 Billion | -132.39 Million |
| Earnings Per Share Basic | -69.81 | -29.38 | -64.29 | - | -39.29 | -0.21 |
| Earnings Per Share Diluted | -69.81 | -29.38 | -64.29 | - | -39.29 | -0.21 |
| Weighted Average Shares Outstanding | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million | 641.71 Million |
| Gross Margin | 0.14 | 0.22 | 0.16 | 0.19 | 0.19 | 0.33 |
| EBIT Margin | -0.02 | 0.01 | -0.12 | - | -0.03 | 0.17 |
| Profit Margin | -0.22 | -0.08 | -0.20 | -0.07 | -0.11 | -0.00 |
| EBITDA | -5.08 Billion | 1.34 Billion | -24.95 Billion | - | -7.78 Billion | 28.89 Billion |
| Earnings Before Tax Margin | -0.05 | -0.00 | -0.16 | -0.00 | -0.04 | 0.15 |
SYMBIOX
ACME
SREEL
H07
FED
BOOZT-DKK